Microba Life Sciences Ltd

Microba Investor Hub - Webinars

Microba Investor Hub

Microba Investor Hub - Corporate Governance

Microba Investor Hub - Shareholder Information

Corporate

Microba Investor Hub - News & Media

Microba Investor Hub - Announcements

DM Sans

Microba Life Sciences Limited (ASX: MAP) ("Microba") is pleased to share the full video recording of CEO Dr. Luke Reid's presentation at the Bell Potter Healthcare Conference which took place on Tuesday 19th November 2024.

In this presentation, Dr. Reid provides an update following Microba's Q1FY25 results and an overview of the Company’s activities and latest developments across its microbiome diagnostics and therapeutics business areas.

This presentation also includes an engaging Q&A session with Thomas Wakim, Bell Potter Healthcare Analyst, where Dr. Reid responds to key investor questions about our strategy, future potential, and the transformative role we aim to play in improving human health.

We value your questions and feedback. Please feel free to submit any questions through the 'Ask a question' button on the right hand side of this screen. 

We sincerely thank Bell Potter for providing this valuable opportunity to engage with our current and prospective shareholders. 

Watch: Microba CEO's Presentation at Bell Potter Healthcare Conference